198 related articles for article (PubMed ID: 32195970)
41. Intraocular inflammatory myofibroblastic tumor with ALK overexpression.
O'Malley DP; Poulos C; Czader M; Sanger WG; Orazi A
Arch Pathol Lab Med; 2004 Jan; 128(1):e5-7. PubMed ID: 14692830
[TBL] [Abstract][Full Text] [Related]
42. Laryngeal inflammatory myofibroblastic tumor (IMT): a case report and review of the literature.
Tay SY; Balakrishnan A
J Med Case Rep; 2016 Jun; 10(1):180. PubMed ID: 27339455
[TBL] [Abstract][Full Text] [Related]
43. ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.
Fan J; Huang B; Yang X; Yang M; He J; Nie X
Diagn Pathol; 2017 Sep; 12(1):68. PubMed ID: 28923119
[TBL] [Abstract][Full Text] [Related]
44. Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.
Zhang S; Yan B; Zheng J; Zhao J; Zhou J
Oncotarget; 2016 Sep; 7(39):63758-63766. PubMed ID: 27563816
[TBL] [Abstract][Full Text] [Related]
45. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.
Butrynski JE; D'Adamo DR; Hornick JL; Dal Cin P; Antonescu CR; Jhanwar SC; Ladanyi M; Capelletti M; Rodig SJ; Ramaiya N; Kwak EL; Clark JW; Wilner KD; Christensen JG; Jänne PA; Maki RG; Demetri GD; Shapiro GI
N Engl J Med; 2010 Oct; 363(18):1727-33. PubMed ID: 20979472
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
[TBL] [Abstract][Full Text] [Related]
47. Uterine inflammatory myofibroblastic tumor with THBS1-INSR fusion.
Sim A; Devouassoux-Shisheboran M; Benmoulay-Rigollot C; Picot T; Péoc'h M; Karpathiou G
Pathol Res Pract; 2023 Jun; 246():154500. PubMed ID: 37156213
[TBL] [Abstract][Full Text] [Related]
48. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene.
Sokai A; Enaka M; Sokai R; Mori S; Mori S; Gunji M; Fujino M; Ito M
Jpn J Clin Oncol; 2014 Jan; 44(1):93-6. PubMed ID: 24277751
[TBL] [Abstract][Full Text] [Related]
50. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects.
Brivio E; Zwaan CM
Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903
[TBL] [Abstract][Full Text] [Related]
51. ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report.
Wang K; Zhou H; Lu Y; Lu Q; Zhang C; Zhou X; Xia S; Wang G
Medicine (Baltimore); 2018 Dec; 97(51):e13619. PubMed ID: 30572472
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review.
Teoh JY; Chan NH; Cheung HY; Hou SS; Ng CF
Urology; 2014 Sep; 84(3):503-8. PubMed ID: 25168523
[TBL] [Abstract][Full Text] [Related]
53. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
[TBL] [Abstract][Full Text] [Related]
54. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
[TBL] [Abstract][Full Text] [Related]
55. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
Zhang YH; Zhang XR; Yu J; Li HL
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
[No Abstract] [Full Text] [Related]
56. [Exceptional bilocular inflammatory myofibroblastic pseudotumour (IMT) characterized by recurrent thoracic tumour growth and a rare (adult) second manifestation within the mesenteric tissue of the small intestine].
Petersen M; Kuester D; Roessner A; Schütte K; Lippert H; Meyer F
Z Gastroenterol; 2010 May; 48(5):555-9. PubMed ID: 20140844
[TBL] [Abstract][Full Text] [Related]
57. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
[TBL] [Abstract][Full Text] [Related]
58. Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor.
Kutok JL; Pinkus GS; Dorfman DM; Fletcher CD
Hum Pathol; 2001 Dec; 32(12):1382-7. PubMed ID: 11774173
[TBL] [Abstract][Full Text] [Related]
59. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors.
Felkai L; Bánusz R; Kovalszky I; Sápi Z; Garami M; Papp G; Karászi K; Varga E; Csóka M
Pathol Oncol Res; 2019 Jan; 25(1):217-224. PubMed ID: 29081033
[TBL] [Abstract][Full Text] [Related]
60. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
